Gastroenterology
Maria Rescigno presents a preclinical study investigating a non-absorbable antibiotic with eubiotic properties in a mouse model of gastrointestinal toxicity induced by the chemotherapeutic agent 5-fluorouracil (5-FU).
MOZAIC, an AI model designed to compare donor and recipients microbiotas, predicted the microbiota convergence after FMT with an accuracy of about 80%.
Microbes migrating from the mouth to the gut may play a role in gastric cancer and could become targets for diagnosis or treatment.
The findings suggest that targeting specific gut microbes or their metabolites could boost fat-burning and metabolism in response to specific diets.
B. luti plays a crucial role in maintaining gut homeostasis, microbial electron transfer and gut health by producing beneficial metabolites and regulating formate and hydrogen levels.
Modulating the gut microbiota could be a new strategy to harness immune cells for treating colorectal cancer.
Gut microbes, through metabolites such as niacin, shape the regional identity and protective functions of colon cells.
The findings suggest that L. salivarius can be a microbiota-based therapy for preventing severe fatty liver disease progression.
Francisco Guarner, from Centro Médico Teknon in Barcelona, discusses the role of probiotics in the prevention of antibiotic-associated diarrhea.
Monitoring shifts in microbial interaction networks could help to detect and track gut-related conditions.
